Hemp

Manitoba Harvest partners with Brightseed to launch bioactive fiber

19-Feb-2024 By Danielle Masterson

Recent AI-led research identified hemp hulls as an untapped source of dietary fiber and gut-health beneficial bioactives. The finding is now opening doors for new partnerships and product developments.

UK food law consultant: Don’t acquiesce to FSA’s new CBD dose opinion

23-Oct-2023 By Stephen Daniells

CBD industry stakeholders should not accept the UK Food Standards Agency’s recent downgrading of the CBD Acceptable Daily Intake (ADI), with recent studies advancing our understanding and potentially opening up opportunities to push for higher levels.

Hemp Beverage Alliance sets out to help the category reach its potential

27-Sep-2023 By Rachel Arthur

Regulatory confusion and poor availability is hampering the success of hemp beverages in the US. But the consumer demand is clearly there, says the newly formed Hemp Beverage Alliance - which believes that, if these challenges are addressed, the category...

Charlotte’s Web-Canopy Growth analysis identifies safe CBD intake levels for supplements

18-Sep-2023 By Claudia Adrien

Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.

‘The risk we have here is enough to manage’: Athlete turned entrepreneur Floyd Landis discusses how regulatory uncertainty threatens the global CBD industry

15-Sep-2023 By Oliver Morrison

Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

CBD alliance to benefit from AI technology

29-Jun-2023 By Olivia Haslam

The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.

NPA's Fabricant on CBD, State-led regulations, and NMN's dangerous precedent

31-Jan-2023 By Stephen Daniells

2023 may be a New Year, but many of the old issues for the dietary supplements industry remain. In this wide-ranging interview with Daniel Fabricant, PhD, CEO of the Natural Products Association, we dug into some of the most front-of-mind issues for this...

FDA to reveal CBD oversight plans soon

06-Jan-2023 By Danielle Masterson

After dragging its feet for nearly five years, the agency is gearing up to make big moves.

CBD in 2022: A year in review

06-Dec-2022 By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

NutraCast: How amendments in the 2023 Farm Bill could shape the hemp industry

13-Oct-2022 By Danielle Masterson

Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?

CBD entrepreneur Floyd Landis to share vision in upcoming NutraIngredients-USA webinar

10-Oct-2022 By Hank Schultz

Some CBD entrepreneurs talk a good game when it comes to their companies’ mission statements. Former pro cyclist Floyd Landis has lived his.

Upcoming webinar to examine tumultuous CBD market

28-Sep-2022 By Hank Schultz

Demand for CBD ingredients remains high and innovation continues apace even as the regulatory uncertainty of the category persists. A panel of influential speakers will delve into these and other questions in an upcoming webinar hosted by NutraIngredients-USA.

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

Provisions of Senate bill could decimate hemp industry, industry group asserts

10-Aug-2022 By Hank Schultz

Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.

Congress explores how Farm Bill could hasten CBD regulations, market development

02-Aug-2022 By Elizabeth Crawford

On Capitol Hill last week, hemp industry stakeholders and Congressional leaders frustrated by FDA’s lack of regulations for CBD and other hemp-derived compounds since the 2018 Farm Bill authorized commercial production of the crop, explored how the 2023...

NutraCast: The fight to make cannabinoid therapy mainstream

29-Jul-2022 By Danielle Masterson

Through research, education, and grants, Realm of Caring is helping those in need of more information about cannabinoid therapies. The non-profit seeks to facilitate and encourage the mainstream acceptance of plant-powered therapies and serve healthcare...

Vertosa, University of Massachusetts Amherst join forces to study CBG

11-Jul-2022 By Danielle Masterson

Researchers say there are more questions than answers surrounding the minor cannabinoid, so the partnership signifies a step in the right direction.

NutraCast: Turning to CBD for mental health

08-Jul-2022 By Danielle Masterson

Between Covid-19, supply chain issues and inflation, life is taking a serious toll on mental health. But more and more people are looking for ways to address mental health without a prescription.

FDA revisits safety of CBD for use in dietary supplements, industry not satisfied

23-Jun-2022 By Asia Sherman

Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.

Kemin enters hemp-CBD space with Luxiva distillates range

15-Jun-2022 By Stephen Daniells

Iowa-based Kemin is expanding its portfolio to introduce a range of USDA-certified organic, traceable, U.S.-grown hemp CBD distillates for use in health and wellness products.

Nutracast: The van Breemen Company launches following groundbreaking hemp study

10-Jun-2022 By Danielle Masterson

Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.

HempRise introduces 5% CBD nanoemulsion

09-Jun-2022 By Danielle Masterson

The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.

Study: Many CBD products would trigger doping bans

09-Jun-2022 By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.

NutraCast: Exploring cannabis terpenes for pain management

03-Jun-2022 By Danielle Masterson

As the stigma surrounding cannabinoids fades, hemp-derived supplements are gaining traction as popular applications for pain management. New research from the University of Arizona Health Sciences in the Comprehensive Pain and Addiction Center have found...

FDA slams Delta-8 THC sellers over claims

04-May-2022 By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

NutraCast: Evo Hemp joins 40-Acre Co-Op to level farming opportunity

22-Apr-2022 By Danielle Masterson

When you picture a farmer, who comes to mind?

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

04-Apr-2022 By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

FDA, FTC slap seven CBD firms with COVID-19 warning letters

01-Apr-2022 By Hank Schultz

Seven marketers of CBD products received warning letters for making COVID-19 treatment claims as part of the ongoing joint FDA/FTC enforcement action.

EU introduces trade harmonisation for hemp seed market

28-Mar-2022 By Nicola Gordon-Seymour

The European Commission has finally agreed maximum THC limits for hemp seed products for the EU market, putting an end to internal market fragmentation.

Six key supplement trends from Expo West 2022

15-Mar-2022 By Stephen Daniells

We walked and we talked, and we took photos, and here’s our editor’s list of 6 key trends for supplements from Expo West 2022 in Anaheim.

Hemp hulls yield phytonutrients targeting liver & metabolic health: Brightseed data

09-Mar-2022 By Stephen Daniells

Compounds from hemp hulls called N-trans caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT) may support liver and metabolic health, according to new data from AI-phytonutrient pioneers Brightseed.

Factoring CBD into the athletic equation

03-Mar-2022 By Danielle Masterson

This year’s Sports & Active Nutrition Summit event launched with a focus on CBD in sports nutrition. While CBD/hemp products are still in a federal regulatory gray area, that hasn’t stopped product developers from flooding the market with new offerings....

Best companies will prevail as CBD market goes through painful winnowing, CEO says

24-Feb-2022 By Hank Schultz

The hemp/CBD market is going through a reckoning but ultimately will emerge in a stronger position, said the head of one of few publicly traded companies in the sector.

NPA submits citizen’s petition demanding resolution on CBD issue

22-Feb-2022 By Hank Schultz

The Natural Products Association has filed a citizen’s petition calling for FDA to either rule that CBD is a legal dietary ingredient or to make a rule allowing enforcement discretion on the substance.

NutraCast: Vertosa CEO Ben Larson on rising growth of infused beverages

28-Jan-2022 By Danielle Masterson

Not long ago, the idea of hemp-infused beverages taking a share of the beer, wine and spirit sales would have been laughable. But some companies are laughing all the way to the bank.

Kemin expands hemp-based ingredients offering with Driftless Extracts investment

20-Jan-2022 By Stephen Daniells

Iowa-based Kemin Industries has made a strategic investment in Wisconsin-based Driftless Extracts LLC, a USDA-certified organic hemp producer, processor, and ingredient supplier.

USP commentary sounds safety, quality alarm on delta-8 THC

03-Dec-2021 By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

How TreeHouse Biosciences is helping brands with its patented THC remediation technology

23-Aug-2021 By Danielle Masterson

Keeping the THC within bounds in full spectrum hemp extracts is creating an opportunity for a company that is offering a remediation service.

CV Sciences’ Q2 revenue rebounds after challenging Q1

13-Aug-2021 By Stephen Daniells

CBD products manufacturer CV Sciences has recorded quarter-on-quarter increases in revenue, with increasing retail distribution and a “strong” innovation pipeline leading to bullish predictions for the rest of 2022.

NutraCast:Tracking CBD experiences in real-time with Releaf App

09-Jul-2021 By Danielle Masterson

More and more companies are using apps to gain insights on their respective industries. With the right data inputs, technology can improve decision making and help company leaders zero in on trends. The Releaf App is one such application that individuals...

COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope

16-Jun-2021 By Shane Starling

The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

20-Apr-2021 By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

CRN’s Mister on the best solution for CBD, DSHEA 2.0, and more

14-Apr-2021 By Stephen Daniells

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...